Kangmei Pharma | 600518 - Ebit

Stock Price
1.75
Daily Change
-0.08 -4.37%
Monthly
-5.91%
Yearly
-7.89%
Q2 Forecast
1.71

Kangmei Pharma reported CNY-26.7M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Avita Medical AUD -10.39M 1.72M Dec/2025
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Genomma Lab Internacional MXN 800.61M 167.16M Dec/2025
Hypermarcas BRL 647.2M 23.33M Dec/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Jiangsu Hengrui CNY 2.25B 848.02M Dec/2025
Kangmei Pharma CNY -26.7M 43.13M Sep/2025
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 28M Sep/2025
Revvity USD 145.83M 47.49M Dec/2025
Sh Fosun Pharma CNY 864.14M 185.2M Dec/2025
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Viatris USD -157.5M 392M Dec/2025
Wuxi Apptec CNY 4.67B 73.59M Dec/2025
Xeris Pharmaceuticals USD 16.77M 8.88M Dec/2025
Zz Pientze Pharmaceu CNY 501.33M 15.6M Sep/2025